23 Sep, 2025 | Admin | No Comments
Stock in Tylenol’s parent company rallies after Trump’s unproven claims
Tylenol’s parent company, Kenvue, saw its stock price rebound in premarket trading on Tuesday after U.S. President Donald Trump made unfounded claims about the drug.
Write Reviews
Leave a Comment
No Comments & Reviews